C. Haasbeek

发表

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Peter Balter, Joe Y. Chang, Joachim Widder, 2015, The Lancet. Oncology.

Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer.

Aaron D Ward, Suresh Senan, Sarah A Mattonen, 2014, Medical physics.

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

Michael Lock, Stewart Gaede, Suresh Senan, 2019, The Lancet.

Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review.

Suresh Senan, Ben J Slotman, S. Senan, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of audio-coaching on the position of lung tumors.

S. Senan, F. Lagerwaard, B. Slotman, 2008, International journal of radiation oncology, biology, physics.

Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery.

L. Stalpers, C. Haasbeek, D. González, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques.

S. Senan, A. Vincent, F. Lagerwaard, 2011, International journal of radiation oncology, biology, physics.

The TRENDY multi-center randomized trial on hepatocellular carcinoma - Trial QA including automated treatment planning and benchmark-case results.

K. Haustermans, B. Heijmen, S. Habraken, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer

N. Aaronson, C. Gundy, S. Senan, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment and survival of second primary early-stage lung cancer, following treatment of head and neck cancer in the Netherlands.

C. Leemans, S. Senan, B. Slotman, 2016, Lung cancer.

Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.

B. Yaremko, M. Lock, S. Senan, 2019, International journal of radiation oncology, biology, physics.

Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy.

S. Senan, F. Lagerwaard, B. Slotman, 2010, Cancer.

Stage I nonsmall cell lung cancer in patients aged ≥75 years

S. Senan, F. Lagerwaard, B. Slotman, 2010, Cancer.

Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis

C. Haasbeek, M. Meijerink, H. Scheffer, 2022, Current Oncology Reports.

Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis.

S. Senan, F. Lagerwaard, A. Louie, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs.

S. Senan, B. Slotman, D. Palma, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Baseline Survey on the Treatment Workflow and Pediatric IGRT Practice Among European Members of the Project-Based Consortium and the Pediatric Radiation Oncology Society (PROS).

B. Hoeben, M. Josipovic, M. Aznar, 2020 .

Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes.

S. Senan, F. Lagerwaard, B. Slotman, 2013, Journal of thoracic disease.

A Brief Report on Outcomes of Stereotactic Ablative Radiotherapy for a Second Primary Lung Cancer: Evidence in Support of Routine CT Surveillance

S. Senan, F. Lagerwaard, B. Slotman, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery.

E. Smit, S. Senan, F. Lagerwaard, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

B. Yaremko, M. Lock, S. Senan, 2019, BMC Cancer.

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

B. Yaremko, M. Lock, S. Senan, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

B. Yaremko, M. Lock, S. Senan, 2020, medRxiv.

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

B. Yaremko, M. Lock, S. Senan, 2012, BMC Cancer.

Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age

B. Hoeben, M. J. van de Vijver, M. Hauptmann, 2018, Neuro-oncology.

Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer

B. Slotman, B. Lissenberg-Witte, W. Verbakel, 2021, Cancers.

A prospective single-arm phase II study of stereotactic magnetic-resonance-guided adaptive radiotherapy for prostate cancer: Early toxicity results.

S. Senan, F. Lagerwaard, C. Haasbeek, 2019, International journal of radiation oncology, biology, physics.

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy

S. Senan, J. R. van Sörnsen de Koste, C. Haasbeek, 2020, Physics and imaging in radiation oncology.

Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy

Timothy K. Nguyen, S. Senan, B. Slotman, 2017, Acta oncologica.

Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial

B. Yaremko, M. Lock, S. Senan, 2018, International Journal of Radiation Oncology*Biology*Physics.

Outcomes of stereotactic body radiotherapy (SBRT) in 175 patients with stage I NSCLC aged 75 years and older.

S. Senan, F. Lagerwaard, C. Haasbeek, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma

W. Vandertop, C. Zwaan, C. Haasbeek, 2017, Journal of Neuro-Oncology.

The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery.

F. Lagerwaard, B. Slotman, G. Rodrigues, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis.

S. Senan, F. Lagerwaard, A. Louie, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors.

S. Senan, F. Lagerwaard, C. Haasbeek, 2020, International journal of radiation oncology, biology, physics.

Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

E. Smit, S. Senan, F. Lagerwaard, 2008, International journal of radiation oncology, biology, physics.

Chapter 9 Optimizing SABR delivery for synchronous multiple lung tumors using volumetric modulated arc therapy

B. Slotman, D. Palma, S. Gaede, 2018 .

Outcomes of stereotactic body radiotherapy in patients with clinical stage I non-small cell lung cancer who are fit to undergo surgery.

S. Senan, F. Lagerwaard, C. Haasbeek, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chapter 4 Outcomes of hypofractionated high dose radiotherapy in poor-risk patients with “ ultracentral ” non-small cell lung cancer

C. Haasbeek, H. Tekatli, 2018 .

Communicating cancer treatment information using the Web: utilizing the patient’s perspective in website development

Daniëlle R. M. Timmermans, Suresh Senan, Olga C. Damman, 2014, BMC Medical Informatics and Decision Making.

Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer

S. Senan, F. Lagerwaard, B. Slotman, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiotherapy for lung cancer: clinical impact of recent technical advances.

Suresh Senan, Ben J Slotman, S. Senan, 2009, Lung cancer.

Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy

S. Senan, F. Lagerwaard, B. Slotman, 2009, Cancer.

Critical review of nonsurgical treatment options for stage I non-small cell lung cancer.

E. Smit, S. Senan, F. Lagerwaard, 2008, The oncologist.

The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis

S. Senan, W. Verbakel, M. Dahele, 2021, JTO clinical and research reports.

Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer.

S. Senan, W. Verbakel, M. Dahele, 2020, Lung cancer.

Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group

J. Fütterer, M. Coolsen, C. Dejong, 2020, Cancers.

Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) - Extended Long-Term Outcomes.

B. Yaremko, M. Lock, S. Senan, 2022, International journal of radiation oncology, biology, physics.

An evaluation of websites providing patient information on stereotactic body radiation therapy (SBRT) for stage I lung cancer in three Western European countries.

O. Damman, S. Senan, B. Slotman, 2012, Journal of radiosurgery and SBRT.

Treatment patterns for adrenal metastases using surgery and SABR during a 10-year period.

S. Senan, C. Haasbeek, A. Becker-Commissaris, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Survival Benefit of Repeat Local Treatment in Patients Suffering From Early Recurrence of Colorectal Cancer Liver Metastases.

G. Kazemier, J. V. van Waesberghe, C. Haasbeek, 2021, Clinical colorectal cancer.

Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.

Suresh Senan, David Palma, George Rodrigues, 2012, International journal of radiation oncology, biology, physics.

Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry

J. V. van Waesberghe, B. Lissenberg-Witte, C. Haasbeek, 2021, Cancers.

The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.

B. Heijmen, K. Muller, H. Ceha, 2020, International journal of radiation oncology, biology, physics.

Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors.

Suresh Senan, Berend J. Slotman, S. Senan, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Suresh Senan, Ben J Slotman, Frank J Lagerwaard, 2012, International journal of radiation oncology, biology, physics.

A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases.

B. Yaremko, F. Lagerwaard, B. Slotman, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

In Reply to Dr. Bauman

S. Senan, F. Lagerwaard, B. Slotman, 2010 .

Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy.

Suresh Senan, Ben J Slotman, Wilko F A R Verbakel, 2009, International journal of radiation oncology, biology, physics.

Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence

D. Knol, E. Sánchez, F. Lagerwaard, 2009, Journal of Neurology.

The ORCHESTRA trial: A phase III trial of adding tumor debulking to systemic therapy versus systemic therapy alone in multi-organ metastatic colorectal cancer (mCRC).

J. Nuyttens, J. Burger, H. Verheul, 2015 .

Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis.

E. Smit, S. Senan, F. Lagerwaard, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

B. Yaremko, M. Lock, S. Senan, 2019, BMC Cancer.

Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.

Suresh Senan, Ben J Slotman, Frank J Lagerwaard, 2012, The Lancet. Oncology.

Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.

C. Reddy, S. Senan, F. Lagerwaard, 2015, International journal of radiation oncology, biology, physics.

Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands.

S. Senan, F. Lagerwaard, B. Slotman, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Stages I-II non-small cell lung cancer treated using either lobectomy by video-assisted thoracoscopic surgery (VATS) or stereotactic ablative radiotherapy (SABR): Outcomes of a propensity score-matched analysis.

E. Smit, S. Senan, F. Lagerwaard, 2012 .

Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography.

S. Senan, J. R. van Sörnsen de Koste, K. Carson, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study

M. J. van de Vijver, M. Hauptmann, M. H. van den Berg, 2018, Journal of the National Cancer Institute.

Safety and Feasibility of Additional Tumor Debulking to First‐Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer

J. Tuynman, J. Nuyttens, H. Verheul, 2020, The oncologist.

Assessment of Response After Stereotactic Ablative Radiation Therapy (SABR) for Lung Cancer: Can Advanced CT Image Feature Analysis Predict Recurrence?

A. Ward, S. Senan, D. Palma, 2013 .

Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: A quantitative analysis of CT density changes

A. Ward, S. Senan, D. Palma, 2013, Acta oncologica.

CT image feature analysis in distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a preliminary study

Aaron D. Ward, Sarah A. Mattonen, David A. Palma, 2013, Medical Imaging.

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Randomized Trial

B. Yaremko, M. Lock, S. Senan, 2020 .

Patient-reported Outcome Measurements on the Tolerance of Magnetic Resonance Imaging-guided Radiation Therapy

Suresh Senan, Shyama Tetar, Ben J. Slotman, 2018, Cureus.

Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease.

S. Senan, F. Lagerwaard, B. Slotman, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer

Suresh Senan, Ben J Slotman, Frank J Lagerwaard, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence

D. Knol, E. Sánchez, F. Lagerwaard, 2009, Journal of Neurology.

Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.

Suresh Senan, Ben J Slotman, Frank J Lagerwaard, 2019, International journal of radiation oncology, biology, physics.

Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?

S. Senan, F. Lagerwaard, B. Slotman, 2007, International journal of radiation oncology, biology, physics.

Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy.

S. Senan, C. Haasbeek, B. Slotman, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accuracy of deformable image registration-based intra-fraction motion management in Magnetic Resonance-guided radiotherapy.

I. Kawrakow, S. Senan, C. Haasbeek, 2023, Physics and Imaging in Radiation Oncology.

Unresectable Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial

M. Coolsen, J. Futterer, S. Jenniskens, 2023, CardioVascular and Interventional Radiology.

Corrigendum to “Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review” [Radiother Oncol 106 (2013) 276–282]

S. Senan, B. Slotman, C. Haasbeek, 2013 .